GETI-B:STO
Getinge publ AB
SEK 250.00
arrow_downward
-0.24%(-0.60) 1D
Oct 7, 5:29:49 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEK 250.40
High
SEK 252.30
Low
SEK 248.40
Mkt. cap
63.00B
Avg. vol.
578.49K
Volume
748.53K
Dividend
1.90%
Quarterly dividend
SEK 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.46
52-wk high
SEK 252.30
52-wk low
SEK 175.90
EPS
SEK 9.82
Shares outstanding
254.15M
No. of employees
12K
Open
SEK 250.40
High
SEK 252.30
Low
SEK 248.40
Mkt. cap
63.00B
Avg. vol.
578.49K
Volume
748.53K
Dividend
1.90%
Quarterly dividend
SEK 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.46
52-wk high
SEK 252.30
52-wk low
SEK 175.90
EPS
SEK 9.82
Shares outstanding
254.15M
No. of employees
12K
News stories
From web sources and news partners
TipRanks
·
3 hours ago
Getinge’s Life Science President Eric Honroth to Step Down
www.marketscreener.com
·
4 hours ago
Getinge's Business Area Head Eric Honroth Leaves the Company
TipRanks
·
9 hours ago
Getinge Schedules Q3 2026 Report Release and Investor Call
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB